REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 108 filers reported holding REGENXBIO INC in Q4 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,198,000 | +150.6% | 16,692 | +4.3% | 1.18% | +97.0% |
Q1 2018 | $478,000 | +7.9% | 16,008 | +19.0% | 0.60% | +16.3% |
Q3 2017 | $443,000 | +61.1% | 13,448 | -3.3% | 0.51% | +57.7% |
Q2 2017 | $275,000 | +15.1% | 13,906 | +12.2% | 0.33% | -2.1% |
Q1 2017 | $239,000 | – | 12,398 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |